Survival of patients with alcoholic and cryptogenic cirrhosis without liver transplantation: A single center retrospective study

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Senanayake, Sudul Mananjala ^a   Niriella, Madunil Anuk ^a,b   Weerasinghe, Sanjaya Kumara ^b   Kasturiratne, Anuradhani ^c   De Alwis, Jerome Praneeth ^b   De Silva, Arjuna Priyadarsin ^a,b   Dassanayake, Anuradha Supun ^d   De Silva, Hithanadura Janaka ^a,b  

^a University Medical Unit   (Sri Lanka)

^b Departments of Medicine   (Sri Lanka)

^c Departments of Public Health   (Sri Lanka)

^d UNIVERSITY OF COLOMBO   (Sri Lanka)

Author keywords

Alcoholic cirrhosis; Cryptogenic cirrhosis; Transplant free survival

Indexed keywords

ADULT; AGE; AGED; ALCOHOL ABSTINENCE; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CAUSE OF DEATH; COMPARATIVE STUDY; DEATH CERTIFICATE; DIABETES MELLITUS; DRINKING BEHAVIOR; FEMALE; HEALTH CARE DELIVERY; HUMAN; KAPLAN MEIER METHOD; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SRI LANKA; TIME;

ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; CAUSE OF DEATH; DEATH CERTIFICATES; DIABETES MELLITUS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SRI LANKA; TEMPERANCE; TIME FACTORS;

MLCS; MLOWN;

EID: 84870212391     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-663     Document Type: Article

References (31)

1. The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Fleming KM, Aithal GP, Card TR, West J, Aliment Pharmacol Ther 2010 32 1343 1350 10.1111/j.1365-2036.2010.04473.x 21050236
2. Transection of the oesophagus for bleeding esophageal varicies. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R, Br J Surg 1973 60 646 649 10.1002/bjs.1800600817 4541913
3. Liver cirrhosis. Schuppan D, Afdhal NH, Lancet 2008 371 838 851 10.1016/S0140-6736(08)60383-9 18328931 (Pubitemid 351323895)
4. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969-2002. Stokkeland K, Brandt L, Ekbom A, Hultcrantz R, Hepatology 2006 43 500 505 10.1002/hep.21089 16496319
5. Long-term Clinical Course of Decompensated Alcoholic Cirrhosis: A Prospective Study of 165 Patients. Alvarez MA, Cirera I, Solà R, Bargalló A, Morillas RM, Planas R, J Clin Gastroenterol 2011 45 10 906 911 10.1097/MCG.0b013e3182284e13 21814145
6. Deaths on the liver transplant waiting list: An analysis of competing risks. Kim WR, Therneau TM, Benson JT, Kremers WK, Rosen CB, Gores GJ, et al. Hepatology 2006 43 345 351 10.1002/hep.21025 16440361
7. Exclusions and deaths on the liver transplant waiting list. Cadahía V, González-Diéguez ML, Alonso P, García-Bernardo C, Miyar de León A, Barneo L, Vázquez L, González-Pinto IM, Rodríguez M, Transplant Proc 2010 42 2 622 624 10.1016/j.transproceed.2010.02.009 20304208
8. Clinical course of alcoholic liver cirrhosis: A Danish population-based cohort study. Jepsen P, Ott P, Andersen PK, Sorenson HT, Vilstrup H, Hepatology 2010 51 5 1675 1682 10.1002/hep.23500 20186844
9. Decompensated cryptogenic and alcoholic cirrhosis in Singapore. A clinical study of 100 patients. Siang SC, Hai TC, Singapore Med J 1965 6 4 207 212 5886276
10. The natural history of cirrhosis. Stone WD, Islam NRK, Paton A, Q J Med 1968 37 119 132 4297954
11. A 20-year prospective study of cirrhosis. Saunders JB, Walters JR, Davies AP, Paton A, Br Med J (Clin Res Ed) 1981 282 6260 263 266 10.1136/bmj.282.6260. 263 (Pubitemid 11188540)
12. Follow-up study of 582 liver cirrhosis patients for 26 years in Japan. Tanaka R, Itoshima T, Nagashima H, Liver 1987 7 6 316 324 3437793 (Pubitemid 18013808)
13. Effect of hepatitis C virus infection and abstinence from alcohol on survival in patients with alcoholic cirrhosis. Serra MA, Escudero A, Rodríguez F, del Olmo JA, Rodrigo JM, J Clin Gastroenterol 2003 36 2 170 174 10.1097/00004836-200302000-00016 12544203 (Pubitemid 36139733)
14. Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit. Bell H, Jahnsen J, Kittang E, Raknerud N, Sandvik L, Scand J Gastroenterol 2004 39 9 858 863 10.1080/00365520410006350 15513384 (Pubitemid 39215457)
15. Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis. Toshikuni N, Izumi A, Nishino K, Inada N, Sakanoue R, Yamato R, et al. J Gastroenterol Hepatol 2009 24 7 1276 1283 10.1111/j.1440-1746.2009.05851.x 19486451
16. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Poonawala A, Nair SP, Thuluvath PJ, Hepatology 2000 32 4 Pt 1 689 692 11003611
17. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ, Hepatology 1999 29 3 664 669 10.1002/hep.510290347 10051466 (Pubitemid 29109578)
18. Cryptogenic cirrhosis in the region where obesity is not prevalent. Kojima H, Sakurai S, Matsumura M, Umemoto N, Uemura M, Morimoto H, et al. World J Gastroenterol 2006 12 13 2080 2085 16610061
19. Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground. Chitturi S, Wong VW, Farrell G, J Gastroenterol Hepatol 2011 26 Suppl 1 163 172 21199528
20. Prevalence of hypertension, diabetes and obesity: baseline findings of a population based survey in four provinces in Sri Lanka. Wijewardene K, Mohideen MR, Mendis S, Fernando DS, Kulathilaka T, Weerasekara D, Uluwitta P, Ceylon Med J 2005 50 2 62 70 16114771 (Pubitemid 44967047)
21. High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Misra IA, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N, Int J Obes 2001 25 1722 1729 10.1038/sj.ijo.0801748 (Pubitemid 33052085)
22. Carbohydrate metabolism dysregulation in cirrhosis: pathophysiology, prognostic impact and therapeutic implications. Buyse S, Valla D, Gastroenterol Clin Biol 2007 31 3 266 273 10.1016/S0399-8320(07)89371-7 17396083 (Pubitemid 46555713)
23. Hepatogenous diabetes. García-Compean D, Jaquez-Quintana JO, Maldonado-Garza H, Current views of an ancient problem. Ann Hepatol. 2009 8 1 13 20
24. Prognostic significance of diabetes in patients with cirrhosis. Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E, Hepatology 1994 20 1 Pt 1 119 125 8020880 (Pubitemid 24196500)
25. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites. Moreau R, Delègue P, Pessione F, Hillaire S, Durand F, Lebrec D, Valla DC, Liver Int 2004 24 5 457 464 10.1111/j.1478-3231.2004. 0991.x 15482343 (Pubitemid 40484560)
26. Impact of diabetes on the severity of liver disease. Hickman IJ, Macdonald GA, Am J Med 2007 120 10 829 834 10.1016/j.amjmed.2007.03.025 17904449 (Pubitemid 47451297)
27. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Nishida T, Tsuji S, Tsujii M, Arimitsu S, Haruna Y, Imano E, et al. Am J Gastroenterol 2006 101 1 70 75 10.1111/j.1572-0241.2005.00307.x 16405536 (Pubitemid 43381711)
28. Abnormal glucose tolerance: a predictor of 30-day mortality in patients with decompensated liver cirrhosis. Hagel S, Bruns T, Herrmann A, Stallmach A, Schmidt C, Z Gastroenterol 2011 49 3 331 334 10.1055/s-0029-1245933 21391163
29. The dissociation between the diabetes and both Child-Pugh score and in-hospital mortality in cirrhotic patients due to hepatitis B, hepatitis C, or alcoholic. Chen YW, Chen HH, Wang TE, Chang CW, Chang CW, et al. Hepatology International 2011 5 4 955 964 10.1007/s12072-011-9274-y
30. Model for end-stage liver disease (MELD) and allocation of donor livers. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Gastroenterology 2003 124 91 96 10.1053/gast.2003.50016 12512033 (Pubitemid 36055342)
31. Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer. Heuman D, Mihas A, Gastroenterology 2003 125 3 992 993 10.1016/S0016-5085(03)01149-1 12974261 (Pubitemid 37070715)